Skip to main content

Articles

Practice Management

Lessons from the Leucovorin Shortages Between 2009 and 2012 in a Medicare Advantage Population: Where Do We Go from Here?

Stakeholder Perspective

Drug Shortages Are Costly to Patients and to Payers

Practice Management

Offering Lung Cancer Screening to High-Risk Medicare Beneficiaries Saves Lives and Is Cost-Effective: An Actuarial Analysis

Stakeholder Perspective

Cost-Effectiveness and the Medicare Budget

Original Research

Impact of Linaclotide Treatment on Work Productivity and Activity Impairment in Adults with Irritable Bowel Syndrome with Constipation: Results from 2 Randomized, Double-Blind, Placebo-Controlled Phase 3 Trials

Stakeholder Perspective

Patient-Reported Outcomes Matter

Beyond Paternalism

Population Health and the Assessment of Value

Stakeholder Integration Needed to Address a Flawed Reimbursement System

Breast Cancer, Oncology

ALTTO: Dual Anti-HER2 Adjuvant Therapy No Better than Trastuzumab Alone

Breast Cancer, Oncology

Less May Be “More” with Zoledronic Acid

Breast Cancer, Oncology

Adjuvant Exemestane More Effective than Tamoxifen in Early-Stage Breast Cancer

Multiple Myeloma, Oncology

Novel Drug Classes Make News in Multiple Myeloma

Page 145 of 244
Results 1441 - 1450 of 2434